Priesner, Christoph;Hildebrandt, Martin
Advanced Therapy Medicinal Products and the Changing Role of Academia.
Transfus Med Hemother
2022
49
3
158-162

Garcia-Manero, Guillermo;Winer, Eric S.;DeAngelo, Daniel J.;Tarantolo, Stefano R.;Sallman, David Andrew;Dugan, James;Groepper, Stefanie;Giagounidis, Aristoteles;Gotze, Katharina S.;Metzeler, Klaus;Li, Chia-Cheng;Zhou, Li;Martinez, Elizabeth;Lane, Maureen E.;Von Roemeling, Reinhard W.;Bohme, Matthias;Kubasch, Anne Sophie;Verma, Amit K.;Platzbecker, Uwe
Phase 1/2a study of the IRAK4 inhibitor CA-4948 as monotherapy or in combination with azacitidine or venetoclax in patients with relapsed/refractory (R/R) acute myeloid leukemia or lyelodysplastic syndrome.
J Clin Oncol
2022
40 Suppl S
16

Götze, Katharina S;Lengerke, Claudia
[Importance of clonal hematopoiesis for hematologic neoplasms].
Inn Med (Heidelb)
2022
63
11
1107-1114

Buehring-Uhle, C.;Smit, P.;Negraschus, A.;Morath, V.;Goldmann, U.;Papadopoulou, A.;Heider, M.;Riviere, J.;Goetze, K.;Heinz, L.;Fluhrer, R.;Moser, M.;Superti-Furga, G.;Bassermann, F.;Eichner, R.
SPPL3 and its substrate glycosyltransferases regulate the N-glycosylation of SLC3A2 and alter the affinities of anti-SLC3A2 immunotherapies in AML
Oncology Research and Treatment
2022
45 Suppl 2
SUPPL 2
95-95

Segura, Sonia Jaramillo;Wass, Maxi;Schaffrath, Judith;Rieger, Kathrin;Nogai, Axel;Haenel, Mathias;Herbst, Regina;Stoelzel, Friedrich;Roellig, Christoph;Jost, Edgar;Schlenk, Richard F.;Noppeney, Richard;Brandts, Christian H.;Krug, Utz;Goetze, Katharina S.;Buske, Sebastian;Florschuetz, Axel;Schubert, Joerg;Opitz, Bernhard;Mohren, Martin;Esseling, Eva;von Witzendorff, Stephan;Subklewe, Marion;Kaufmann, Martin;Frickhofen, Norbert;Scholz, Christian W.;Schaefer-Eckart, Kerstin;Kunzmann, Volker;Schmidt-Hieber, Martin;Sayer, Herbert G.;Rank, Andreas;Hemmati, Philipp;Schueler, Frank;Kowoll, Simone;Scheller, Marina;Steighardt, Jorg;Edemir, Bayram;Mueller, Lutz Peter;Gliko-Kabir, Irit;Ludwig-Kraus, Beatrice;Edemir, Sabine;Sorani, Ella;Binder, Mascha;Vainstein, Abi;Kadosh, Shaul;Gromann, Cora;Wienke, Andreas;Baldus, Claudia D.;Platzbecker, Uwe;Serve, Hubert;Bornhaeuser, Martin;Junghanss, Christian;Mueller-Tidow, Carsten
Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups
Blood
2022
140 Suppl 1
3338-3340

Lopez Cadenas, Felix;Lumbreras, Eva;Gonzalez, Teresa;Xicoy, Blanca;Sanchez-Garcia, Joaquin;Coll, Rosa;Slama, Bohrane;Angel Hernandez-Rivas, Jose;Thepot, Sylvain;Bernal, Teresa;Guerci-Bresler, Agnes;Sanz, Guillermo;Bargay, Joan;Luz Amigo, Maria;De Paz Arias, Raquel;Preudhomme, Claude;Giagounidis, Aristoteles;Platzbecker, Uwe;Wickenhauser, Stefan;Goetze, Katharina S.;Arar, Ali;Hernandez Rivas, Jesus M.;Toribio Castello, Sofia M.;Fenaux, Pierre;Del Canizo, Consuelo;Diez-Campelo, Maria
Evaluation of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent Low Risk Del(5q) MDS Patients. Final Results of Sintra-REV Phase III International Multicenter Clinical Trial
Blood
2022
140 Suppl 1
1109-1111

Lang, Jonas B;Buck, Michèle C;Rivière, Jennifer;Stambouli, Oumaima;Sachenbacher, Ken;Choudhary, Purva;Dietz, Hendrik;Giebel, Bernd;Bassermann, Florian;Oostendorp, Robert A J;Götze, Katharina S;Hecker, Judith S
Comparative analysis of extracellular vesicle isolation methods from human AML bone marrow cells and AML cell lines.
Front Oncol
2022
12

Brandmeier, Lisa;Ecker, Veronika;Stumpf, Martina;Giansanti, Piero;Moreira, Aida Varela;Pfeuffer, Lisa;Fens, Marcel;Lu, Junyan;Kuester, Bernhard;Engleitner, Thomas;Heidegger, Simon;Ringshausen, Ingo;Zenz, Thorsten;Wendtner, Clemens-Martin;Mueschen, Markus;Ruland, Juergen;Buchner, Maike
Negative Feedback Regulation of MAPK Signaling Is an Important Driver of CLL Progression
Blood
2022
140 Suppl 1
9840-9841

Doehner, Hartmut;Weber, Daniela;Krzykalla, Julia;Fiedler, Walter;Kuehn, Michael W. M.;Schroeder, Thomas;Mayer, Karin;Luebbert, Michael;Wattad, Mohammad;Goetze, Katharina;Fransecky, Lars;Koller, Elisabeth;Wulf, Gerald;Schleicher, Jan;Ringhoffer, Mark;Greil, Richard;Hertenstein, Bernd;Krauter, Juergen;Martens, Uwe M.;Nachbaur, David;Abu Samra, Maisun;Machherndl-Spandl, Sigrid;Basara, Nadezda;Leis, Claudia;Schrade, Anika;Kapp-Schwoerer, Silke;Bullinger, Lars;Thol, Felicitas R.;Heuser, Michael;Paschka, Peter;Gaidzik, Verena;Saadati, Maral;Benner, Axel;Schlenk, Richard F.;Doehner, Konstanze;Ganser, Arnold
Gemtuzumab Ozogamicin Plus Intensive Chemotherapy for Patients with NPM1-Mutated Acute Myeloid Leukemia
Blood
2022
140 Suppl 1
2010-2013

Baer, Constance;Huber, Sandra;Hutter, Stephan;Meggendorfer, Manja;Nadarajah, Niroshan;Walter, Wencke;Platzbecker, Uwe;Gotze, Katharina;Kern, Wolfgang;Haferlach, Torsten;Hoermann, Gregor;Haferlach, Claudia
Risk Prediction in MDS: A Validation of the IPSS-M and Comparison to IPSS-R and to Two Other Personalized Prediction Tools
Blood
2022
140 Suppl 1
1128-1129